Literature DB >> 5022098

A method for the determination of dopa and 3-O-methyldopa in the plasma of Parkinsonian patients.

G Curzon, B D Kantamaneni, J Trigwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5022098     DOI： 10.1016/0009-8981(72)90453-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  8 in total

1.  Amphetamines, growth hormone and narcolepsy.

Authors:  J D Parkes; A G Debono; P Jenner; J Walters
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

2.  Plasma dopa concentrations after different preparations of levodopa in normal subjects.

Authors:  J G Morris; R L Parsons; J R Trounce; M J Groves
Journal:  Br J Clin Pharmacol       Date:  1976-12       Impact factor: 4.335

3.  Systemic activity of orally administered L-dopa in the elderly Parkinson patient.

Authors:  M A Evans; E J Triggs; G A Broe; N Saines
Journal:  Eur J Clin Pharmacol       Date:  1980       Impact factor: 2.953

4.  Plasma DOPA levels and growth hormone response to levodopa in parkinsomism.

Authors:  A Galea-Debono; P Jenner; C D Marsden; J D Parkes; D Tarsy; J Walters
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-02       Impact factor: 10.154

5.  The absorption and metabolism of a standard oral dose of levodopa in patients with Parkinsonism.

Authors:  S Bergmann; G Curzon; J Friedel; R B Godwin-Austen; C D Marsden; J D Parkes
Journal:  Br J Clin Pharmacol       Date:  1974-10       Impact factor: 4.335

6.  The effect of low dose carbidopa/levodopa on prolactin and growth hormone concentrations in patients with breast cancer and in benign breast tumours.

Authors:  M K Jones; I D Ramsay; P G Jenner
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

7.  Dopamine and serotonin metabolism in hepatic encephalopathy.

Authors:  A J Knell; A R Davidson; R Williams; B D Kantamaneni; G Curzon
Journal:  Br Med J       Date:  1974-03-23

8.  Changes in electroretinogram and serum potassium during L-DOPA treatment in parkinsonism.

Authors:  D Terziivanov; M Filipova; I Janků; J Balík; V Filip; L Stika
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1983
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.